Neuland Laboratories Ltd.NSE: NEULANDLAB

Press Release Apr 01 2026

· Issued by Neuland Laboratories Ltd.

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-apr-01-2026-5

Sarada Bhamidipati Company Secretary Encl: As above Saharsh Davuluri takes over as CEO & MD of Neuland and will lead the next phase of CDMO expansion Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities Hyderabad, India, April 01, 2026: Neuland Laboratories [NLL] (NSE: NEULANDLAB; BSE:524558), a global contract development and

Neuland Laboratories Ltd. on 6ix

Earlier from Neuland Laboratories

Later from Neuland Laboratories

All Neuland Laboratories news releases